Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 100.39 Million | USD 171.34 Million | 6.12% | 2023 |
The global Hemostasis market size accrued earnings worth approximately USD 100.39 Million in 2023 and is predicted to gain revenue of about USD 171.34 Million by 2032, is set to record a CAGR of nearly 6.12% over the period from 2024 to 2032.
The study includes drivers and restraints for the Hemostasis Valves Market along with the impact they have on the demand over the estimated period. Additionally, the report includes the study of opportunities available in the hemostasis valves market on a global level.
Hemostasis is a process that helps to bleed to stop from the injured blood vessel. During this process, the blood changes from liquid to a gelatinous state. The entire process of hemostasis has three steps which are blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis valves are mostly used in angioplasty and angiography procedures to reduce blood loss during the procedure. After locking the valve it builds the pressure inside the vessel and reduces the blood loss. It reduces the opening time during catheter insertion and also reduces the risk of thromboembolism. The hemostasis valve is regularly used in neuroendovascular methods to lessen the risk of thromboembolism. The hemostasis valve is made up of plastic and has two ports lateral and proximal. The lateral end is used for flushing and proximal end has a seal which is used for closing the catheter to prevent blood flow.
There are various factors driving the growth of hemostasis valves market over the forecast timeframe which includes the escalating demand for a minimally invasive procedure such as angiography, angioplasty, and others. Furthermore, an increase in the number of hospitals, rising population, and the increasing number of interventional procedures are expected to propel the growth of hemostasis valves market.
Moreover, technological advancement, increase in healthcare facilities, and favorable market scenarios are expected to create lucrative opportunities for hemostasis valves market in the near future. However, a complex monitoring procedure is expected to inhibit the growth of hemostasis valves market over the foreseeable future.
In order to give the users of this report a comprehensive view of the hemostasis valves market, we have included a competitive landscape and an analysis of Porter’s Five Forces model in the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved on the market on a global and regional basis.
The hemostasis valves market is classified into product type, application, and end user.
Based on product type, the hemostasis valve market is segmented into Y-connectors hemostasis valve, one-handed hemostasis valves, double Y-connector hemostasis valves, and other hemostasis valves. Hemostasis valve Y-connectors segment is expected to dominate the hemostasis valves market in terms of revenue.
Based on application, the hemostasis valves market is classified into angiography and angioplasty. The angiography segment is expected to account for the largest market share over the forecast period.
On the basis of end users, the hemostasis valves market is segmented into ambulatory surgical centers, hospitals, and others. Hospital segment is likely to dominate the hemostasis valves market in terms of market share over the estimated timeframe.
Report Attributes | Report Details |
---|---|
Report Name | Hemostasis Valves Market |
Market Size in 2023 | USD 100.39 Million |
Market Forecast in 2032 | USD 171.34 Million |
Growth Rate | CAGR of 6.12% |
Number of Pages | 205 |
Key Companies Covered | Boston Scientific Inc., Abbott Laboratories, Argon Medical, B. Braun Melsungen AG, Deroyal Industries, Inc., Freudenberg Medical, Merit Medical Systems, Scitech, Teleflex Incorporated, and Terumo Corporation, among others |
Segments Covered | By product type, By application, By end-user and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The key regions covered in the hemostasis valves market include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is predicted to dominate the hemostasis valves market in the near future due to the presence of developed countries. Europe is anticipated to closely follow North America in terms of growth. The Asia Pacific is likely to develop significantly due to the presence of developing countries. Latin America and the Middle East & African markets are expected to develop considerably over the timespan
Some major players of the global hemostasis valves market include
Global Hemostasis Valves Market: Product Type Analysis
Global Hemostasis Valves Market: Application Analysis
Global Hemostasis Valves Market: End-user Analysis
Global Hemostasis Valves Market: Regional Analysis
FrequentlyAsked Questions
Hemostasis valves are medical devices that are employed in a variety of procedures, particularly in catheter-based interventions and minimally invasive surgeries, to regulate the passage of blood or other fluids. These valves are essential for the preservation of hemostasis, which is the cessation or regulation of hemorrhage, during procedures that necessitate access to blood vessels or body cavities.
The demand for hemostasis valves is driven by the increasing prevalence of cardiovascular conditions, such as coronary artery diseases, which necessitate catheter-based procedures.
The global Hemostasis market size accrued earnings worth approximately USD 100.39 Million in 2023 and is predicted to gain revenue of about USD 171.34 Million by 2032.
The global Hemostasis market is set to record a CAGR of nearly 6.12% over the period from 2024 to 2032.
The key regions covered in the hemostasis valves market include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is predicted to dominate the hemostasis valves market in the near future due to the presence of developed countries. Europe is anticipated to closely follow North America in terms of growth. The Asia Pacific is likely to develop significantly due to the presence of developing countries. Latin America and the Middle East & African markets are expected to develop considerably over the timespan
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed